Abstract
A crucial subset of priceless treatments, life-saving medications have a special non-market value that makes them more significant than buying and selling. Drugs cannot be regarded as ordinary goods since they save lives and are necessary to
monitor country-level progress toward Universal Health Coverage. Yet medicines account for one-fourth of all health spending worldwide. Drug manufacturers are frequently under pressure to prudently (i.e., low) price these medications.
Drug accessibility, availability, and affordability are all impacted by drug costs. Runaway healthcare expenses are mostly attributed to rising prescription drug prices. The price of essential and life-saving drugs, the country’s National Essential
medicine lists, and how readily available they are in South and South East Asia are the topics of this paper.
Keywords: Life-saving drugs; Essential Medicines; South Asia; South-East Asia
Download the paper here:
